Results 221 to 230 of about 1,018,202 (279)

Respiratory Organ‐on‐a‐Chip for Disease Modeling: From Architecture to Functional Integration

Advanced Healthcare Materials, EarlyView.
Respiratory organ‐on‐a‐chip (ROC) models capture key mechanical and cellular cues of the human respiratory system, enabling quantitative dissection of disease mechanisms. This review links ROC architectures to disease modeling, functional integration, and commercialization, and proposes a decision framework that aligns model complexity with mechanistic
Jinzhuo Hu, Yongjie Tang, Sidi Liu, Tao Xu, Qian Liu   +4 more
wiley   +1 more source

Prognostic comparison between osteoblastic and osteolytic metastases in prostate cancer. [PDF]

Glob Health Med
Ono A, Akiyama K, Nishimoto R, Amakawa R, Inoue Y, Yoshimatsu T, Shiga Y, Kusakabe M, Yamada H, Taguchi S, Kume H, Nakamura M.   +11 more
europepmc   +1 more source

Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25. [PDF]

Cancer Immunol Immunother
Roviello G, Gambale E, De Gennaro Aquino I, Maruzzo M, Messina C, Vascotto IA, Rossi V, Bimbatti D, Erbetta E, Messina M, Mennitto A, Rebuzzi SE, Nasso C, Mercinelli C, Catalano M, Maiorano BA, Fanelli M, Sorarù M, Scolari F, Mela MM, Galli L, Salfi A, Rizzo M, Puglisi S, Orlando V, Fornarini G, Rametta A, Giannatempo P, Cerbone L, Doni L, Pillozzi S, Antonuzzo L.   +31 more
europepmc   +1 more source

Pseudocirrhosis due to liver metastasis from lung squamous cell carcinoma: A case report. [PDF]

Oncol Lett
Liu Q, Lu Y, Wang D, Yao J, Liu Y.
europepmc   +1 more source

Single-cell advances in the investigation of the pathogenesis and treatment of brain metastasis. [PDF]

Neurooncol Adv
Porter RS, Alves-Pereira C, Brastianos PK.   +2 more
europepmc   +1 more source

Radiotherapy for the management of bone metastases in differentiated thyroid cancer. [PDF]

Clin Transl Radiat Oncol
Faulkner C, Mesci A, Alfadli F, Brierley JD, Tsang R, Ye XY, Mete O, Ma L, Barron C, Krzyzanowska MK, Lukovic J.   +10 more
europepmc   +1 more source

First-Line Enfortumab Vedotin Plus Pembrolizumab in Platinum-Ineligible Urothelial Carcinoma: A Three-Case Series. [PDF]

Cureus
Igarashi D, Kaneko G, Takamatsu K, Shirotake S, Oyama M.   +4 more
europepmc   +1 more source